Abstract

BackgroundThe cellular protein eukaryotic translation elongation factor 1A (eEF1A) binds to aminoacylated transfer RNAs and delivers them to the ribosome during translation. eEF1A also binds to RNA secondary structures present in genomes of several RNA viruses and plays important roles in their replication. As a RNA binding protein, whether eEF1A can bind with HIV-1 genomic RNA has not been investigated and was the aim of the study.MethodsRNA-protein interaction was determined by reversible crosslink co-immunoprecipitation (RC-Co-IP) and biolayer Interferometry assay (BLI). eEF1A binding region within RNA was mapped by deletion and mutation analysis. Virus with genomic RNA mutations were examined for eEF1A-RT interaction by proximity ligation assay, for reverse transcription by qPCR and for replication by CAp24 ELISA in cells.ResultsThe interaction of eEF1A with 5’UTR of HIV-1 genomic RNA was detected in cells and in vitro. Truncation and substitution mutations in the 5’UTR RNA demonstrated that a stem-loop formed by nucleotides 142 to 170, which encompass a reported tRNA anticodon-like-element, binds to eEF1A. Mutations that altered the stem-loop structure by changing two highly conserved sequence clusters in the stem-loop region result in reduction of the interaction with eEF1A in vitro. HIV-1 virus harbouring the same 5’UTR mutations significantly reduced the interaction of eEF1A with HIV-1 reverse transcription complex (RTC), reverse transcription and replication.ConclusioneEF1A interacts with 5’UTR of HIV-1 genomic RNA and the interaction is important for late DNA synthesis in reverse transcription.

Highlights

  • The cellular protein eukaryotic translation elongation factor 1A binds to aminoacylated transfer RNAs and delivers them to the ribosome during translation. eEF1A binds to RNA secondary structures present in genomes of several RNA viruses and plays important roles in their replication

  • HIV-1 genomic RNA binds to eEF1A in infected cells To examine whether eEF1A interacts with HIV-1 genomic RNA, RC-co-IP experiment was performed in HIV-1 infected TMZ-bl cells using an anti-eEF1A antibody in the presence /absence of an HIV-1 reverse transcriptase inhibitor, nevirapine

  • There was a large amount of HIV-1 RNA detected in samples from HIV-1 infected cells compared to infection with heat-inactivated virus (p < 0.05), which are defective for viral entry, indicating that HIV-1 RNA co-immunoprecipitated with eEF1A (Fig. 1a)

Read more

Summary

Introduction

The cellular protein eukaryotic translation elongation factor 1A (eEF1A) binds to aminoacylated transfer RNAs and delivers them to the ribosome during translation. eEF1A binds to RNA secondary structures present in genomes of several RNA viruses and plays important roles in their replication. The cellular protein eukaryotic translation elongation factor 1A (eEF1A) binds to aminoacylated transfer RNAs and delivers them to the ribosome during translation. EEF1A binds to RNA secondary structures present in genomes of several RNA viruses and plays important roles in their replication. The eukaryotic translation elongation factor 1A (eEF1A) is a subunit of the eukaryotic translation elongation 1 complex (eEF1) and its canonical role in translational elongation is to bind and deliver aminoacylated transfer RNAs (aa-tRNAs) to the elongating ribosome. Our recent study demonstrated that eEF1A associates with the HIV-1 reverse transcription complex (RTC) and plays an important role in HIV-1 reverse transcription [12]. Whether eEF1A can interact with HIV-1 genomic RNA, as it does with other RNA viruses, in order to facilitate association with the HIV-1 RTC has not been investigated

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.